Marginal note:PCT sequence listing standard
58 (1) If a specification discloses a nucleotide sequence or amino acid sequence other than a sequence identified as forming a part of the prior art, the description must contain, in respect of that sequence, a sequence listing in electronic form and both the electronic form and the content of the sequence listing must comply with the PCT sequence listing standard.
Marginal note:One copy per application
(2) An application for a patent must not contain more than one copy of a particular sequence listing regardless of its form of presentation.
Marginal note:Statement — application originally filed without sequence listing
(3) If an application for a patent originally filed without a sequence listing is amended to include one, the applicant must file a statement that the listing does not go beyond the disclosure in the application as filed.
Marginal note:Statement — application not in compliance
(4) If a sequence listing filed in paper form that does not comply with the PCT sequence listing standard or in an electronic form that does not comply with the PCT sequence listing standard is replaced by a sequence listing in an electronic form that does comply with that standard, the applicant must file a statement that the replacement listing does not go beyond the disclosure in the application for a patent as originally filed.
Marginal note:Definitions
(5) The following definitions apply in this section.
- amino acid sequence
amino acid sequence has the same meaning as in the PCT sequence listing standard. (séquence d’acides aminés)
- nucleotide sequence
nucleotide sequence has the same meaning as in the PCT sequence listing standard. (séquence de nucléotides)
- Date modified: